[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - New England …, 2014 - mayoclinic.elsevierpure.com
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp… - 2014 - pubmed.ncbi.nlm.nih.gov
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
[PDF][PDF] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
L Mauri, DJ Kereiakes, RW Yeh… - New England journal …, 2014 - boris.unibe.ch
BACKGROUND Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
[引用][C] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
L MAURI, DJ KEREIAKES… - The New England …, 2014 - pascal-francis.inist.fr
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
L Mauri, DJ Kereiakes, RW Yeh… - N Engl J …, 2014 - academicworks.medicine.hofstra …
BACKGROUND Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
[HTML][HTML] Twelve or 30 Months of Dual Antiplatelet Therapy After Drug-eluting Stents
L Mauri, DJ Kereiakes, RW Yeh… - The New England …, 2014 - ncbi.nlm.nih.gov
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
L Mauri, DJ Kereiakes, RW Yeh… - The New England …, 2014 - europepmc.org
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
[引用][C] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
L Mauri, DJ Kereiakes, RW Yeh… - New England Journal …, 2014 - cir.nii.ac.jp
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp… - jichi.ac.jp
冠動脈ステント留置術後の抗血小板薬 2 剤併用療法 (DAPT) は, 血栓性合併症を防ぐために推奨
されているが, 臨床医は出血のリスクを常に懸念する. 加えて, 1 年を超えて継続することのリスクと …
されているが, 臨床医は出血のリスクを常に懸念する. 加えて, 1 年を超えて継続することのリスクと …